Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch Physiol Biochem ; 123(1): 23-30, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27424611

RESUMO

AIM: We evaluated the potential preventive and therapeutic effects of Crataegus aronia (C. aronia) in NAFLD induced by high-fat diet (HFD) in rat models. METHODS: Protective effect of Crataegus aronia or simvastatin was investigated in Wistar rats fed either low-fat diet (LFD) or HFD. RESULTS: Liver histopathological examinations confirmed the development of NAFLD in rats fed HFD. In both protective and therapeutic treatments, C. aronia significantly reduced liver index (3.85 ± 0.21% in HFD plus aronia group versus 6.22 ± 0.58% in HFD model group), increased the HDL-cholesterol and reduced the LDL-cholesterol in blood. The hawthorn plant also significantly ameliorated oxidative stress biomarker (p < 0.002) and liver enzymes (p < 0.0001) that indicate liver damage. CONCLUSION: C. aronia exhibits therapeutic and protective effects on NAFLD in an animal model possibly by its lipid lowering and antioxidant effects; thus, may offer therapeutic potential in humans.


Assuntos
Anticolesterolemiantes/uso terapêutico , Antioxidantes/uso terapêutico , Lipotrópicos/uso terapêutico , Fígado/efeitos dos fármacos , Hepatopatia Gordurosa não Alcoólica/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/uso terapêutico , Animais , Anticolesterolemiantes/efeitos adversos , Anticolesterolemiantes/isolamento & purificação , Antioxidantes/efeitos adversos , Antioxidantes/isolamento & purificação , Biomarcadores/sangue , Biomarcadores/metabolismo , HDL-Colesterol/agonistas , HDL-Colesterol/sangue , LDL-Colesterol/antagonistas & inibidores , LDL-Colesterol/sangue , Crataegus/efeitos adversos , Crataegus/química , Crataegus/crescimento & desenvolvimento , Dieta com Restrição de Gorduras , Dieta Hiperlipídica/efeitos adversos , Jordânia , Lipotrópicos/efeitos adversos , Lipotrópicos/isolamento & purificação , Fígado/metabolismo , Fígado/patologia , Fígado/fisiopatologia , Masculino , Hepatopatia Gordurosa não Alcoólica/tratamento farmacológico , Hepatopatia Gordurosa não Alcoólica/patologia , Hepatopatia Gordurosa não Alcoólica/fisiopatologia , Componentes Aéreos da Planta/química , Componentes Aéreos da Planta/crescimento & desenvolvimento , Extratos Vegetais/efeitos adversos , Extratos Vegetais/isolamento & purificação , Distribuição Aleatória , Ratos Wistar , Sinvastatina/efeitos adversos , Sinvastatina/uso terapêutico
2.
Mem. Inst. Oswaldo Cruz ; 110(1): 75-85, 03/02/2015. graf
Artigo em Inglês | LILACS | ID: lil-741624

RESUMO

In our previous study, we have found that 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]-pyrimidin-4-ylamine (BAY 41-2272), a guanylate cyclase agonist, activates human monocytes and the THP-1 cell line to produce the superoxide anion, increasing in vitro microbicidal activity, suggesting that this drug can be used to modulate immune functioning in primary immunodeficiency patients. In the present work, we investigated the potential of the in vivo administration of BAY 41-2272 for the treatment of Candida albicans and Staphylococcus aureus infections introduced via intraperitoneal and subcutaneous inoculation. We found that intraperitoneal treatment with BAY 41-2272 markedly increased macrophage-dependent cell influx to the peritoneum in addition to macrophage functions, such as spreading, zymosan particle phagocytosis and nitric oxide and phorbol myristate acetate-stimulated hydrogen peroxide production. Treatment with BAY 41-2272 was highly effective in reducing the death rate due to intraperitoneal inoculation of C. albicans, but not S. aureus. However, we found that in vitro stimulation of peritoneal macrophages with BAY 41-2272 markedly increased microbicidal activities against both pathogens. Our results show that the prevention of death by the treatment of C. albicans-infected mice with BAY 41-2272 might occur primarily by the modulation of the host immune response through macrophage activation. .


Assuntos
Animais , Camundongos , Adipócitos Brancos/metabolismo , Ananas/química , Suplementos Nutricionais , Frutas/química , Hipoglicemiantes/isolamento & purificação , Resíduos Industriais/análise , Extratos Vegetais/isolamento & purificação , Adipogenia , Adipócitos Brancos/citologia , Antioxidantes/química , Antioxidantes/economia , Antioxidantes/isolamento & purificação , Inibidores Enzimáticos/química , Inibidores Enzimáticos/economia , Inibidores Enzimáticos/isolamento & purificação , Indústria de Processamento de Alimentos/economia , Glicosilação , Glicerolfosfato Desidrogenase/antagonistas & inibidores , Glicerolfosfato Desidrogenase/metabolismo , Inibidores de Glicosídeo Hidrolases/química , Inibidores de Glicosídeo Hidrolases/economia , Inibidores de Glicosídeo Hidrolases/isolamento & purificação , Hipoglicemiantes/química , Hipoglicemiantes/economia , Índia , Resíduos Industriais/economia , Lipotrópicos/química , Lipotrópicos/economia , Lipotrópicos/isolamento & purificação , Extratos Vegetais/química , Extratos Vegetais/economia , Solventes/química , alfa-Amilases/antagonistas & inibidores , alfa-Amilases/metabolismo
3.
Br J Nutr ; 112(6): 886-99, 2014 Sep 28.
Artigo em Inglês | MEDLINE | ID: mdl-25201301

RESUMO

Black bean (Phaseolus vulgaris L.) seed coats are a rich source of natural compounds with potential beneficial effects on human health. Beans exert hypolipidaemic activity; however, this effect has not been attributed to any particular component, and the underlying mechanisms of action and protein targets remain unknown. The aim of the present study was to identify and quantify primary saponins and flavonoids extracted from black bean seed coats, and to study their effects on lipid metabolism in primary rat hepatocytes and C57BL/6 mice. The methanol extract of black bean seed coats, characterised by a HPLC system with a UV-visible detector and an evaporative light-scattering detector and HPLC-time-of-flight/MS, contained quercetin 3-O-glucoside and soyasaponin Af as the primary flavonoid and saponin, respectively. The extract significantly reduced the expression of SREBP1c, FAS and HMGCR, and stimulated the expression of the reverse cholesterol transporters ABCG5/ABCG8 and CYP7A1 in the liver. In addition, there was an increase in the expression of hepatic PPAR-α. Consequently, there was a decrease in hepatic lipid depots and a significant increase in bile acid secretion. Furthermore, the ingestion of this extract modulated the proportion of lipids that was used as a substrate for energy generation. Thus, the results suggest that the extract of black bean seed coats may decrease hepatic lipogenesis and stimulate cholesterol excretion, in part, via bile acid synthesis.


Assuntos
Colagogos e Coleréticos/uso terapêutico , Suplementos Nutricionais , Flavonoides/uso terapêutico , Lipotrópicos/uso terapêutico , Phaseolus/química , Saponinas/uso terapêutico , Sementes/química , Animais , Ácidos e Sais Biliares/metabolismo , Células Cultivadas , Colagogos e Coleréticos/química , Colagogos e Coleréticos/isolamento & purificação , Colagogos e Coleréticos/metabolismo , Colesterol/metabolismo , Flavonoides/química , Flavonoides/isolamento & purificação , Flavonoides/metabolismo , Regulação da Expressão Gênica , Hepatócitos/citologia , Hepatócitos/enzimologia , Hepatócitos/metabolismo , Metabolismo dos Lipídeos , Lipotrópicos/química , Lipotrópicos/isolamento & purificação , Lipotrópicos/metabolismo , Receptores X do Fígado , Masculino , México , Camundongos , Camundongos Endogâmicos C57BL , Receptores Nucleares Órfãos/agonistas , Receptores Nucleares Órfãos/genética , Receptores Nucleares Órfãos/metabolismo , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/metabolismo , Extratos Vegetais/uso terapêutico , Distribuição Aleatória , Ratos , Saponinas/química , Saponinas/isolamento & purificação , Saponinas/metabolismo
4.
J Sci Food Agric ; 94(5): 834-40, 2014 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-24166097

RESUMO

The prevalence of obesity is associated with many health-related problems. Currently, more than 300 million people are considered to be obese. According to the World Health Organization (WHO), by 2030, 87 and 439 million people will be affected in India and the world, respectively. Today, herbal medicines are gaining interest in the treatment of obesity and diabetes, because of their minimal side effects. Gymnemic acid - an active component isolated from Gymnema sylvestre - has anti-obesity and antidiabetic properties, decreases body weight and also inhibits glucose absorption. Several components extracted from Gymnema prevent the accumulation of triglycerides in muscle and liver, and also decrease fatty acid accumulation in the circulation. In this paper, an attempt has been made to review the effects of various extracts from Gymnema sylvestre in the regulation of carbohydrate and lipid metabolism in both animal and clinical studies.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Suplementos Nutricionais , Gymnema sylvestre/química , Hipoglicemiantes/uso terapêutico , Lipotrópicos/uso terapêutico , Extratos Vegetais/uso terapêutico , Folhas de Planta/química , Animais , Fármacos Antiobesidade/efeitos adversos , Fármacos Antiobesidade/química , Fármacos Antiobesidade/isolamento & purificação , Diabetes Mellitus Tipo 2/dietoterapia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/metabolismo , Sacarose Alimentar/antagonistas & inibidores , Sacarose Alimentar/metabolismo , Suplementos Nutricionais/efeitos adversos , Suplementos Nutricionais/análise , Humanos , Hipoglicemiantes/efeitos adversos , Hipoglicemiantes/química , Hipoglicemiantes/isolamento & purificação , Absorção Intestinal/efeitos dos fármacos , Metabolismo dos Lipídeos/efeitos dos fármacos , Lipotrópicos/efeitos adversos , Lipotrópicos/química , Lipotrópicos/isolamento & purificação , Obesidade/dietoterapia , Obesidade/tratamento farmacológico , Obesidade/metabolismo , Extratos Vegetais/efeitos adversos , Extratos Vegetais/química , Extratos Vegetais/isolamento & purificação , Saponinas/efeitos adversos , Saponinas/análise , Saponinas/uso terapêutico , Solventes/química , Triterpenos/efeitos adversos , Triterpenos/análise , Triterpenos/uso terapêutico , Redução de Peso/efeitos dos fármacos
5.
J Sci Food Agric ; 94(5): 943-50, 2014 Mar 30.
Artigo em Inglês | MEDLINE | ID: mdl-23929507

RESUMO

BACKGROUND: Rapid urbanisation and nutritional transition is fuelling the increased global incidence of type 2 diabetes. Pineapple fruit residue was explored for its nutraceutical properties as an alternative or adjunct to currently available treatment regime. Ethyl acetate and methanolic extracts of pineapple fruit residue were evaluated for anti-diabetic activity in cell free and cell based systems. Specifically, we assessed: (1) antioxidant potential, (2) anti-glycation potential, (3) carbohydrate digestive enzyme inhibition, and (4) lipid accumulation and glycerol-3-phosphate dehydrogenase activity in differentiating 3T3-L1 cells. RESULTS: The active components in the ethyl acetate and methanolic extracts were identified as sinapic acid, daucosterol, 2-methylpropanoate, 2,5-dimethyl-4-hydroxy-3(2H)-furanone, methyl 2-methylbutanoate and triterpenoid ergosterol using DART/HRMS and ESI/HRMS. Micronutrient analysis revealed the presence of magnesium, potassium and calcium. Adipogenic potential, anti-glycation property of the ethyl acetate extract, and DNA damage protection capacity of the methanolic extract are promising. CONCLUSION: Results from this study clearly indicate that pineapple fruit residue could be utilised as a nutraceutical against diabetes and related complications.


Assuntos
Adipócitos Brancos/metabolismo , Ananas/química , Suplementos Nutricionais , Frutas/química , Hipoglicemiantes/isolamento & purificação , Resíduos Industriais/análise , Extratos Vegetais/isolamento & purificação , Células 3T3-L1 , Adipócitos Brancos/citologia , Adipogenia , Animais , Antioxidantes/química , Antioxidantes/economia , Antioxidantes/isolamento & purificação , Inibidores Enzimáticos/química , Inibidores Enzimáticos/economia , Inibidores Enzimáticos/isolamento & purificação , Indústria de Processamento de Alimentos/economia , Glicerolfosfato Desidrogenase/antagonistas & inibidores , Glicerolfosfato Desidrogenase/metabolismo , Inibidores de Glicosídeo Hidrolases/química , Inibidores de Glicosídeo Hidrolases/economia , Inibidores de Glicosídeo Hidrolases/isolamento & purificação , Glicosilação , Hipoglicemiantes/química , Hipoglicemiantes/economia , Índia , Resíduos Industriais/economia , Lipotrópicos/química , Lipotrópicos/economia , Lipotrópicos/isolamento & purificação , Camundongos , Extratos Vegetais/química , Extratos Vegetais/economia , Solventes/química , alfa-Amilases/antagonistas & inibidores , alfa-Amilases/metabolismo
6.
Lipids Health Dis ; 11: 24, 2012 Feb 13.
Artigo em Inglês | MEDLINE | ID: mdl-22330327

RESUMO

BACKGROUND: To elucidate whether rice protein can possess a vital function in improving lipids level and adiposity, the effects of rice proteins extracted by alkaline (RP-A) and α-amylase (RP-E) on triglyceride metabolism were investigated in 7-week-old male Wistar rats fed cholesterol-enriched diets for 2 weeks, as compared with casein (CAS). RESULTS: Compared with CAS, plasma concentrations of glucose and lipids were significantly reduced by RP-feeding (P < 0.05), as well as hepatic accumulation of lipids (P < 0.05). RP-A and RP-E significantly depressed the hepatic activities of fatty acid synthase (FAS), glucose 6-phosphate dehydrogenase (G6PD) and malate dehydrogenase (MDH) (P < 0.05), whereas the activities of lipoprotein lipase (PL) and hepatic lipase (HL) were significantly stimulated (P < 0.05), as compared to CAS. Neither lipids level nor activities of enzymes were different between RP-A and RP-E (P > 0.05). There was a significant positive correlation between protein digestibility and deposit fat (r = 0.8567, P < 0.05), as well as the plasma TG concentration (r = 0.8627, P < 0.05). CONCLUSIONS: The present study demonstrates that rice protein can modify triglyceride metabolism, leading to an improvement of body weight and adiposity. Results suggest that the triglyceride-lowering action as well as the potential of anti-adiposity induced by rice protein is attributed to upregulation of lipolysis and downregulation of lipogenesis, and the lower digestibility of rice protein may be the main modulator responsible for the lipid-lowering action.


Assuntos
Adiposidade/efeitos dos fármacos , Fármacos Antiobesidade/farmacologia , Lipídeos/sangue , Lipotrópicos/farmacologia , Oryza/química , Extratos Vegetais/farmacologia , Proteínas de Plantas/farmacologia , Triglicerídeos/metabolismo , Redução de Peso/efeitos dos fármacos , Alanina Transaminase/sangue , Aminoácidos/sangue , Animais , Fármacos Antiobesidade/isolamento & purificação , Aspartato Aminotransferases/sangue , Dieta Hiperlipídica , Fezes/química , Lipogênese/efeitos dos fármacos , Lipólise/efeitos dos fármacos , Lipotrópicos/isolamento & purificação , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Masculino , Extratos Vegetais/isolamento & purificação , Proteínas de Plantas/isolamento & purificação , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...